Improvements in Metabolic Syndrome by Xanthohumol Derivatives Are Linked to Altered Gut Microbiota and Bile Acid Metabolism.
Yang ZhangGerd BobeJohana S RevelRichard R RodriguesThomas J SharptonMary L FantaconeKareem RaslanCristobal L MirandaMalcolm B LowryPaul R BlakemoreAndrey MorgunNatalia ShulzhenkoClaudia S MaierJan F StevensAdrian F GombartPublished in: Molecular nutrition & food research (2019)
Changes in the gut microbiota and bile acid metabolism may explain, in part, the improvements in obesity and MetS associated with administration of XN and its derivatives.